David E. Gerber

Jul 1, 2024 | jitc.bmj.com | David E. Gerber |Bonnie Bermas |Alexa Meara

Immune related adverse event - irAEImmune Checkpoint InhibitorSurvivorshipMore than a decade into the remarkable era of cancer immunotherapy, we are facing major challenges with the toxicities of the revolutionary immune checkpoint inhibitor (ICI) therapies. While ICIs have substantially improved survival rates for melanoma and lung cancer among other malignancies, we are in the nascent stage of understanding and management of their adverse events.

Nov 2, 2023 | healio.com | Jennifer Byrne |David E. Gerber |Mindy Valcarcel

You've successfully added Hematology Oncology: Gastrointestinal Cancer to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers at UT Southwestern Medical Center have introduced a new metric that may be useful in predicting which patients are likely to develop immunotherapy toxicity.

Jul 6, 2023 | pubmed.ncbi.nlm.nih.gov | David E. Gerber

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software

Jun 15, 2023 | jamanetwork.com | Caitlin Murphy |David E. Gerber

An Updated Report on the Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer in the Surveillance, Epidemiology, and End Results Program The population of cancer survivors in the US continues to increase.1 Three authors of the present study reported in 2018 that 18.4% of adults newly diagnosed with cancer (2009-2013) survived a previous cancer and may therefore be excluded from cancer clinical trials.2 Many organizations3 have since recommended considering cancer survivors who...

Jun 1, 2023 | jamanetwork.com | David E. Gerber

In January 2023, the Biden administration announced its intent to end the COVID-19 public health emergency on May 11, 2023. The sunsetting of this declaration, in place since early 2020, has numerous implications.